Primary graft dysfunction in heart transplantation: the challenge to survival
- PMID: 38824545
- PMCID: PMC11143673
- DOI: 10.1186/s13019-024-02816-6
Primary graft dysfunction in heart transplantation: the challenge to survival
Abstract
Primary graft dysfunction (PGD) is a life-threatening clinical condition with a high mortality rate, presenting as left, right, or biventricular dysfunction within the initial 24 h following heart transplantation, in the absence of a discernible secondary cause. Given its intricate nature, definitive definition and diagnosis of PGD continues to pose a challenge. The pathophysiology of PGD encompasses numerous underlying mechanisms, some of which remain to be elucidated, including factors like myocardial damage, the release of proinflammatory mediators, and the occurrence of ischemia-reperfusion injury. The dynamic characteristics of both donors and recipients, coupled with the inclination towards marginal lists containing more risk factors, together contribute to the increased incidence of PGD. The augmentation of therapeutic strategies involving mechanical circulatory support accelerates myocardial recovery, thereby significantly contributing to survival. Nonetheless, a universally accepted treatment algorithm for the swift management of this clinical condition, which necessitates immediate intervention upon diagnosis, remains absent. This paper aims to review the existing literature and shed light on how diagnosis, pathophysiology, risk factors, treatment, and perioperative management affect the outcome of PGD.
Keywords: Allogreft; Heart transplantation; Management; Primary graft dysfunction.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
Conflict of interest statement
The authors declare no competing interests.
References
-
- Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation Report-2017; focus theme: allograft ischemic time. J Heart lung Transplantation: Official Publication Int Soc Heart Transplantation. 2017;36(10):1037–46. doi: 10.1016/j.healun.2017.07.019. - DOI - PubMed
-
- Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report–2013; focus theme: age. J Heart lung Transplantation: Official Publication Int Soc Heart Transplantation. 2013;32(10):951–64. doi: 10.1016/j.healun.2013.08.006. - DOI - PubMed
-
- Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. J Heart lung Transplantation: Official Publication Int Soc Heart Transplantation. 2014;33(4):327–40. doi: 10.1016/j.healun.2014.02.027. - DOI - PubMed
-
- Listijono DR, Watson A, Pye R, Keogh AM, Kotlyar E, Spratt P, et al. Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction. J Heart lung Transplantation: Official Publication Int Soc Heart Transplantation. 2011;30(7):783–9. doi: 10.1016/j.healun.2011.01.728. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
